Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Reports NanoStilbene™ Protects the Immune System from Cancer Chemotherapy
September 09, 2019 09:00 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today new data and the filing of a patent application covering the...
Therapeutics Solutions International, Inc LOGO.png
Feng Lin, MD, Ph.D., Joins Therapeutic Solutions International as Chief Scientific Officer
September 03, 2019 09:00 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today the recruitment of Feng Lin, MD, Ph.D., as...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Inc. Reports Revenues Up 850% for Q2
August 29, 2019 13:53 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- via NetworkWire - Therapeutics Solutions International Inc. (OTC: TSOI) today reports that its second-quarter 2019 revenues increased 850%, as...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System in Advanced Cancer Patients
August 26, 2019 09:00 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today positive results from a pilot clinical trial...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Collaborates with Right to Try Foundation on Novel Means of Protecting Patients While Hyper-accelerating Drug Development
August 05, 2019 09:00 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Therapeutics Solutions International, Inc., (OTC Markets: TSOI) together with The Right to Try Foundation announced filing of a...
Therapeutics Solutions International, Inc LOGO.png
NanoStilbene™ Nutraceutical Shown to Increase Ability of Cyclophosphamide Chemotherapy to Suppress Cancer
July 29, 2019 09:00 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- NetworkWire – Therapeutics Solutions International, Inc., (OTC Markets: TSOI) reported today positive animal data demonstrating synergy at...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Cancer Immunotherapy in Animal Model of Cancer
July 22, 2019 09:00 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc. (OTC Markets: TSOI) reported today positive animal data demonstrating synergy...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International adds Nano Cannabidiol to NanoMyros for Inhibition of Microvesicle and Exosome Release in Prostate Cancer
July 15, 2019 09:00 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Therapeutic Solutions International, Inc. (OTC Markets: TSOI) announced today the addition of nano particle cannabidiol to NanoMyros in the form...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Develops Adjuvant Technology to Enhance Prostate Cancer Suppressing Properties of NanoPSA
July 11, 2019 09:00 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today the further development of a mustard seed...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Develops Glucoraphanin + NanoStilbene Encapsulated product for reduction of Prostate Specific Antigen (PSA)
July 08, 2019 09:00 ET | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced today the development of a broccoli sprout extract...